의료용 AI 앱 시장 규모, 점유율 및 동향 분석 보고서 : 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Medical AI Apps Market Summary

The global medical AI apps market size was estimated at USD 1.2 billion in 2025 and is projected to reach USD 4.8 billion by 2033, growing at a CAGR of 19.1% from 2026 to 2033. The increasing adoption of digital health and mobile health (mHealth) technologies, the shift toward personalized and preventive healthcare, the growing focus on early detection and screening programs, and the growth of digital therapeutics (Dtx) and software-based interventions are factors driving market growth.

Moreover, advancements in AI technologies and data availability, increasing regulatory approvals and support for AI-based software (SAMD), and rising investments and strategic collaborations are further propelling market growth.

Market Drivers and Dynamics:

The medical AI apps industry is driven by the growing adoption of digital health and mobile health (mHealth) technologies, along with a shift toward personalized and preventive care. Increasing emphasis on early detection and screening programs, coupled with the expansion of digital therapeutics (DTx) and software-based interventions, is further accelerating demand. In addition, advancements in AI technologies and the rising availability of healthcare data are further enhancing application capabilities and propelling market growth.

Global Medical AI Apps Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the medical AI apps market report based on application, end use and region:

• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Medical Imaging & Diagnostics
• Clinical Decision Support Systems (CDSS)
• Remote Patient Monitoring
• Hospital Workflow & Administrative AI
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Diagnostics & Imaging Centers
• Clinics
• Ambulatory Surgery Centers (ASCs)
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Application
  • 1.2.2. End Use
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Medical AI Apps Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
  • 3.2.3. Industry Challenge Analysis
  • 3.2.4. Industry Opportunity Analysis
• 3.3. Medical AI Apps Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political Landscape
    • 3.3.2.2. Economic Landscape
    • 3.3.2.3. Social Landscape
    • 3.3.2.4. Technology Landscape
    • 3.3.2.5. Environmental Landscape
    • 3.3.2.6. Legal Landscape
• 3.4. Use Cases Analysis

Chapter 4. Medical AI Apps Market: Application Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Medical AI Apps Market: Application Movement Analysis, USD Million, 2025 & 2033
• 4.3. Medical Imaging & Diagnostics
  • 4.3.1. Medical Imaging & Diagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Clinical Decision Support Systems (CDSS)
  • 4.4.1. Clinical Decision Support Systems (CDSS) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Remote Patient Monitoring
  • 4.5.1. Remote Patient Monitoring Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Hospital Workflow & Administrative AI
  • 4.6.1. Hospital Workflow & Administrative AI Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Others
  • 4.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Medical AI Apps Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Medical AI Apps Market: End Use Movement Analysis, USD Million, 2025 & 2033
• 5.3. Hospitals
  • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Diagnostics & Imaging Centers
  • 5.4.1. Diagnostics & Imaging Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Clinics
  • 5.5.1. Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Ambulatory Surgery Centers (ASCs)
  • 5.6.1. Ambulatory Surgery Centers (ASCs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Medical AI Apps Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2025 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
• 6.4. North America
  • 6.4.1. U.S.
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Regulatory framework
    • 6.4.1.3. Competitive scenario
    • 6.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.4.2. Canada
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.4.3. Mexico
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.5. Europe
  • 6.5.1. UK
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5.2. Germany
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5.3. France
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5.4. Italy
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5.5. Spain
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5.6. Norway
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5.7. Sweden
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Regulatory framework
    • 6.5.7.3. Competitive scenario
    • 6.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5.8. Denmark
    • 6.5.8.1. Key country dynamics
    • 6.5.8.2. Regulatory framework
    • 6.5.8.3. Competitive scenario
    • 6.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Japan
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6.2. China
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6.3. India
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6.4. Australia
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6.6. Thailand
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.7. Latin America
  • 6.7.1. Brazil
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7.2. Argentina
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.8. MEA
  • 6.8.1. South Africa
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Regulatory framework
    • 6.8.1.3. Competitive scenario
    • 6.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.8.2. Saudi Arabia
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.8.3. UAE
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Regulatory framework
    • 6.8.3.3. Competitive scenario
    • 6.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.8.4. Kuwait
    • 6.8.4.1. Key country dynamics
    • 6.8.4.2. Regulatory framework
    • 6.8.4.3. Competitive scenario
    • 6.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2025
• 7.4. Company Profiles/Listing
  • 7.4.1. Flo Health Inc., Flo Health UK Limited
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Welldoc, Inc.
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. SkinVision
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Binah.ai
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Aidoc
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Viz.ai
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Qure.ai
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Lillia
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. LeanTaaS
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Artera (Formerly WELL Health)
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. Qventus
    • 7.4.11.1. Company overview
    • 7.4.11.2. Financial performance
    • 7.4.11.3. Product benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. Altera Digital Health Inc.
    • 7.4.12.1. Company overview
    • 7.4.12.2. Financial performance
    • 7.4.12.3. Product benchmarking
    • 7.4.12.4. Strategic initiatives
  • 7.4.13. Sensely, Inc.
    • 7.4.13.1. Company overview
    • 7.4.13.2. Financial performance
    • 7.4.13.3. Product benchmarking
    • 7.4.13.4. Strategic initiatives